Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [04/30/2025 14:55 PDT] Akero Therapeutics, Inc. (NASDAQ:AKRO), Up By 100% ($37.6) From $37.6 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/30/2025 12:42 PDT] Akero Therapeutics, Inc. (NASDAQ:AKRO), Up By 100% ($37.44) From $37.44 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/29/2025 07:38 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [04/17/2025 07:02 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [04/15/2025 07:44 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [04/08/2025 16:11 PDT] Akero Therapeutics, Inc. (NASDAQ:AKRO), Down By 100% ($38.64) From $38.64 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/07/2025 10:29 PDT] Akero Therapeutics, Inc. (NASDAQ:AKRO), Down By 100% ($43.58) From $43.58 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/04/2025 07:37 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [04/03/2025 07:29 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [04/02/2025 07:11 PDT] AKRO Expected to Trade Down Short Term
• [03/31/2025 07:47 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [03/28/2025 07:32 PDT] sector Stocks Expected To Be Down After Top Correlated Stocks Fire Sell Signals.
• [03/17/2025 07:39 PDT] AKRO, Expected to Trade Lower After Bearish Insider Trading
• [03/13/2025 07:20 PDT] AKRO, Expected to Trade Lower After Bearish Insider Trading
• [03/10/2025 07:52 PDT] AKRO Expected to Trade Up After Bullish Patterns Develop
• [03/03/2025 07:42 PST] AKRO Expected to Trade Up After Bullish Patterns Develop